Latest / Pharmacy Podcast Network / Digital Health Community Pharmacy Innovation: HLTH 2024 Podcast Series | HLTH Part Three
Transcript
- 0:05Speaker 1: You are listening to the global network of podcasters dedicated
- 0:08Speaker 1: to the pharmacy profession. Welcome to the Pharmacy Podcast Network.
- 0:24Speaker 2: The Pharmacy Podcast Network is excited to announce the release
- 0:28Speaker 2: of a compelling three part podcast series that covers the
- 0:31Speaker 2: recent HLTH twenty twenty four conference held in Las Vegas
- 0:35Speaker 2: from October twenty second to the twenty fourth. This premier
- 0:38Speaker 2: event gathered thought leaders and innovators from across the healthcare landscape,
- 0:43Speaker 2: focused on addressing pressing challenges and exploring promising opportunities for
- 0:47Speaker 2: the future of health.
- 0:48Speaker 3: Hey, this is Kate how vice president of Ipcicare Plus
- 0:52Speaker 3: brand and program Manager.
- 0:54Speaker 4: I'm here with the Pharmacy Podcast.
- 0:57Speaker 5: I'm here with Kate Health with See Digital Health.
- 1:01Speaker 6: Okate, it's been really fun to hang out with you
- 1:04Speaker 6: here in Vegas at the HLT twenty twenty four. This
- 1:08Speaker 6: is my second time and it's still overwhelming of how
- 1:11Speaker 6: massive this conference is.
- 1:12Speaker 7: Oh.
- 1:12Speaker 3: Absolutely, we were pretty surprised at how big and just
- 1:16Speaker 3: the different types of vendors that we were able to
- 1:18Speaker 3: meet with and interact with.
- 1:19Speaker 4: And it was very encouraging.
- 1:21Speaker 6: Yeah, so representation of independent community pharmacy was here through
- 1:25Speaker 6: IPC it's very proud of the conversations I watched your
- 1:28Speaker 6: team members have Ashton and several organizations that had nothing
- 1:32Speaker 6: to do with physicians and everything to do with patient
- 1:35Speaker 6: engagement are now looking at care plus as a plug
- 1:40Speaker 6: in in order to get access to more and more
- 1:42Speaker 6: patients that are being pulled through independent pharmacies and pharmacy care.
- 1:47Speaker 6: So give us your give these listeners that are tuned
- 1:50Speaker 6: in right now, your overview of health and why it
- 1:54Speaker 6: was important to be here.
- 1:56Speaker 3: I think it was incredibly important to be here because,
- 1:59Speaker 3: as you just stayed, we really were the only voice
- 2:02Speaker 3: I believe for independent pharmacy at this conference, and with
- 2:05Speaker 3: the different vendors and partners that we talked with, they
- 2:09Speaker 3: also reiterated the same thing I had. Many that came
- 2:12Speaker 3: and said, you know, I don't know of any solution
- 2:14Speaker 3: for independent pharmacy that I've ever heard of that it
- 2:17Speaker 3: takes the approach that I care plus takes, And I
- 2:20Speaker 3: think that it's so important for us and for the
- 2:23Speaker 3: industry to understand that independent pharmacy is here to stay.
- 2:26Speaker 3: They're a vital part of their community and they are
- 2:29Speaker 3: a very very important part to how a community really
- 2:32Speaker 3: grows and continues to thrive, and I think really I
- 2:34Speaker 3: Care plus gives them that ability to.
- 2:37Speaker 4: Elaborate and bring that value back where it's needed.
- 2:40Speaker 6: When I watched you talk with people that came into
- 2:43Speaker 6: the booth, a couple of physicians, innovators, technology companies, IDEO,
- 2:48Speaker 6: which is an ADI developer, the expression on the face
- 2:52Speaker 6: is when you said, oh, no, this is already working.
- 2:55Speaker 6: This isn't a future bake, This isn't something that's it's
- 2:58Speaker 6: forward than innovation.
- 3:00Speaker 5: It's already working innovation.
- 3:02Speaker 6: Once again, share that with our listeners that we're saying, no,
- 3:06Speaker 6: this is a system that's working right now in fifty
- 3:09Speaker 6: community pharmacies.
- 3:10Speaker 5: Throughout the country.
- 3:11Speaker 3: Yeah, as you just said, we have fifty live virtual
- 3:13Speaker 3: health care centers. So for us and really being able
- 3:17Speaker 3: to grow this brand, it is getting the folks and
- 3:20Speaker 3: stakeholders that we want to be a part of this
- 3:21Speaker 3: vision to understand that we are integrated.
- 3:24Speaker 4: We are a plug and play program product.
- 3:27Speaker 3: That is something that's very accessible for our pharmacy partners
- 3:31Speaker 3: to ultimately adapt.
- 3:32Speaker 4: And so that was a.
- 3:34Speaker 3: Huge, huge part in what we wanted to cultivate and
- 3:37Speaker 3: create with this particular environment because we know that pharmacy
- 3:41Speaker 3: is involved in so many different aspects. They're being pulled
- 3:43Speaker 3: in so many different directions, and for us to be
- 3:46Speaker 3: able to give them a fully integratable solution but also
- 3:50Speaker 3: not make them do all the legwork and you know,
- 3:53Speaker 3: incorporate all those bells and whistles to get there was
- 3:56Speaker 3: really really vital for our particular program.
- 3:58Speaker 5: And get paid.
- 4:00Speaker 4: Oh you mentioned getting paid. Is that important to a
- 4:03Speaker 4: pharmacy I didn't know that.
- 4:05Speaker 3: Absolutely, get paid for their services and continue to get paid.
- 4:08Speaker 4: We have the structure now in place that you know,
- 4:10Speaker 4: they're getting paid for those particular visits.
- 4:12Speaker 3: But we see a vision that's a bit further than
- 4:14Speaker 3: that and really just really kind of going after how
- 4:17Speaker 3: that future model we'll continuing to integrate into their workflow
- 4:20Speaker 3: so it's a continuous system and they continue to build
- 4:23Speaker 3: upon those payment schedules.
- 4:25Speaker 6: Kate, this has been a great meeting for us as
- 4:28Speaker 6: your press partner. Thanks for having the Pharmacy Podcast Network
- 4:31Speaker 6: as part of this coverage of HLT twenty twenty four.
- 4:35Speaker 3: Thank you so much, and I'm impressed by your network
- 4:37Speaker 3: and everybody that I've seen at the booth as well,
- 4:39Speaker 3: So thank you so much for being here with us.
- 4:46Speaker 6: HLTCH twenty twenty four, bringing together healthcare organizations focused on innovation.
- 4:53Speaker 5: This is what we're doing here.
- 4:54Speaker 6: So much fun to have a pharmacy organization like IPC
- 4:58Speaker 6: concentrated on community pharmacy.
- 5:01Speaker 5: In twenty twenty two, I came.
- 5:02Speaker 6: To health for the first time and one of the
- 5:05Speaker 6: organizations that I met there was ix Layer, and what
- 5:09Speaker 6: I was so impressed with was their depth of knowledge
- 5:12Speaker 6: of how point of care testing can really make a
- 5:14Speaker 6: difference in preventative medicine as well as follow up to
- 5:18Speaker 6: whatever disease state that they're honed in on and the
- 5:22Speaker 6: data that comes from that.
- 5:23Speaker 5: Deborah Harris is the vice president of Marketing.
- 5:27Speaker 6: Thank you, market Deborah Harris is the head of marketing
- 5:30Speaker 6: at ix Layer. She's here with me now and the
- 5:33Speaker 6: IPC both Welcome to the HLTH post shop.
- 5:36Speaker 8: Thanks so much for having me.
- 5:38Speaker 5: All right, thank you so much for coming over and
- 5:40Speaker 5: talking with me.
- 5:41Speaker 6: I was fascinated by ix Layer when I originally learned
- 5:45Speaker 6: about you. However, the things have changed, and not only
- 5:49Speaker 6: you as the head of marketing, but you're actually now
- 5:53Speaker 6: pivoting a bit and where you're going and where you're
- 5:57Speaker 6: with the partnerships that you're building, give our list there's
- 6:00Speaker 6: an update on ix layer.
- 6:01Speaker 9: Yeah, I mean, I think that everyone that's been listening
- 6:04Speaker 9: to what's happening at Health twenty twenty four this year
- 6:06Speaker 9: is seeing that the combination of tech and pharma is
- 6:11Speaker 9: really being discussed, even more so than AI at this
- 6:15Speaker 9: convention this year, and so we're right at the epicenter
- 6:18Speaker 9: of this connectivity between biopharma companies and technology as these
- 6:23Speaker 9: companies look to get closer to their patients.
- 6:26Speaker 6: So what I remember about ix layer is being able
- 6:30Speaker 6: to execute a home based test, receive the data back
- 6:34Speaker 6: to a platform that shared that data with the physician
- 6:39Speaker 6: and the patient through a mobile app, and then of
- 6:41Speaker 6: course an interface to probably the electronic health record. Once again,
- 6:45Speaker 6: talk to our listeners about what ix layer is doing
- 6:49Speaker 6: and spell that out and give us more detail on it.
- 6:51Speaker 9: Yeah, I mean, the basis of our product has not shifted.
- 6:55Speaker 9: The I aix layer stands for the infrastructure, and that's
- 6:58Speaker 9: what you were referencing all the back end technology that
- 7:01Speaker 9: allows for secure transfer of lab testing information, communication with physicians.
- 7:08Speaker 8: And the X stands for the experience.
- 7:10Speaker 9: So that's the front end patient experience that delivers the
- 7:13Speaker 9: convenience that everyone is talking about connecting their lab tests
- 7:17Speaker 9: with their physicians, with prescriptions and the entire ecosystem. So
- 7:21Speaker 9: now we've really developed the infrastructure to support a full
- 7:25Speaker 9: end and direct to patient solution that biopharma companies can
- 7:30Speaker 9: offer to the patients that they're looking to serve.
- 7:33Speaker 6: Now, Deborah, that's the pivot that we were talking about,
- 7:37Speaker 6: because originally rix Layer was moving towards the physician, the pharmacy.
- 7:46Speaker 6: Possibly now the manufacturers involved, where they know their disease state,
- 7:52Speaker 6: they know what would best hone in on the condition
- 7:56Speaker 6: based on executing a test and getting the data back.
- 8:00Speaker 6: Talk to us about that new initiative and relationships.
- 8:03Speaker 9: Yeah, so we're still supporting our two sort of initial
- 8:07Speaker 9: industry verticals in the pharmacy space. We're still providing kits
- 8:12Speaker 9: to consumers and we're still supporting payers. But this new
- 8:16Speaker 9: area has been a focus in biopharma about a year now,
- 8:21Speaker 9: and it really is about understanding the patient journey. And
- 8:24Speaker 9: you reference that these pharmaceutical manufacturers have very very deep
- 8:27Speaker 9: knowledge about the pain points and the areas that these
- 8:31Speaker 9: patients need extra support, extra convenience.
- 8:33Speaker 8: And that's where we come in.
- 8:35Speaker 9: We partner to understand exactly what that patient journey looks
- 8:38Speaker 9: like and where we can have the appropriate intervention, whether
- 8:42Speaker 9: that's lab testing to help people get diagnosis more quickly,
- 8:46Speaker 9: or speak to their physicians so they can get diagnosed
- 8:48Speaker 9: more quickly, or telehealth to speak with a physician all
- 8:52Speaker 9: the way through to prescriptions delivery.
- 8:55Speaker 6: All right, why did you choose to invest your time
- 9:00Speaker 6: the budgeting to come to HLTH Because as this is
- 9:04Speaker 6: an amazing innovation conference, it's also it's an expensive investment
- 9:08Speaker 6: to be here and to have the meetings that lead
- 9:11Speaker 6: to business development, which is my.
- 9:13Speaker 5: Favorite thing to talk about.
- 9:14Speaker 9: Yeah, well, you know, listen, this is my first time here,
- 9:17Speaker 9: so I wasn't really sure what to expect. I know,
- 9:19Speaker 9: I X Layer has been here historically, so with this
- 9:22Speaker 9: new pivot, I wanted to get a sense for how
- 9:25Speaker 9: many biopharma companies are here, what's being discussed in terms
- 9:30Speaker 9: of direct patient care, And what I'm seeing is that
- 9:33Speaker 9: we are at the very forefront, the very beginnings of
- 9:36Speaker 9: this evolution that we think is going to rapidly pick up.
- 9:39Speaker 5: This is great.
- 9:41Speaker 6: I want to invite you back to dig into some
- 9:44Speaker 6: of our subject matter experts, dig into pediatrics, dig into geriatrics,
- 9:49Speaker 6: and caring for our fragile seniors, long term care community.
- 9:55Speaker 6: I think there's so much knowledge that you could help
- 9:58Speaker 6: bring to our listeners and really digging into where pharma
- 10:03Speaker 6: testing and community pharmacy kind of crossroads. And then the
- 10:07Speaker 6: specialty realm is a whole nother discussion that we could
- 10:10Speaker 6: dig into specialty pharmacy disease states too.
- 10:12Speaker 5: I would love that.
- 10:13Speaker 8: Yeah, that sounds great than.
- 10:15Speaker 6: Debbie Harris, how can people reach out to you to
- 10:17Speaker 6: best find you?
- 10:19Speaker 9: You can go to our website ixlier dot com. I'm
- 10:22Speaker 9: on LinkedIn as well, Debrah Harris, you can see me
- 10:24Speaker 9: as the head of marketing.
- 10:26Speaker 8: Those are those two most bass excellent.
- 10:28Speaker 5: Thank you for being part of the show. We are
- 10:35Speaker 5: at hl THH twenty twenty four.
- 10:37Speaker 6: And when I'm thinking of digital health and I'm thinking
- 10:40Speaker 6: of fusion of healthcare, which is the.
- 10:44Speaker 5: Entire environment, there's a part of this.
- 10:49Speaker 6: Group, this ecosystem, which is paying for things, and it's
- 10:53Speaker 6: one of the most irritating parts of pharmacy for me,
- 10:56Speaker 6: which is the PBM. And the three big biggest PBMs
- 11:01Speaker 6: are getting beat up finally by the FTC and starting
- 11:04Speaker 6: to get dissected for really understanding what's going on. It's
- 11:08Speaker 6: the PBMs that started making decisions ten years ago. It
- 11:12Speaker 6: started putting time and effort in building the next gen
- 11:17Speaker 6: pharmacy benefit manager and one of those is Capital RX.
- 11:21Speaker 6: And I've been so proud of Aj and his team
- 11:23Speaker 6: and what he's done.
- 11:25Speaker 5: And I have the honor of.
- 11:26Speaker 6: Interviewing Kristen Begley. She is actually doctor Kristin Begley, farm D, part.
- 11:33Speaker 5: Of the Capital RX team. I want to welcome you
- 11:35Speaker 5: to the show.
- 11:36Speaker 8: Thank you so much and please call me Kristen.
- 11:38Speaker 5: Thrilled to be here, absolutely all right.
- 11:40Speaker 6: Kristen, So talk to us about digital health being at health.
- 11:45Speaker 5: Why did Capital RX decide to come to this conference.
- 11:48Speaker 8: Well, we're very excited to be here.
- 11:51Speaker 10: We think that we're representing change and obviously we are
- 11:54Speaker 10: a very strong advocate for technology moving and advancing our
- 11:58Speaker 10: industry which is lags severely and obviously obviously a lot
- 12:03Speaker 10: of interest players that have been out in the marketplace too.
- 12:05Speaker 8: So thrilled to be here.
- 12:06Speaker 5: Excellent, all right.
- 12:08Speaker 6: So setting the stage, we know that pharmacy care is
- 12:14Speaker 6: in the plate tectonics change from the role of the
- 12:17Speaker 6: pharmacist provider status and then now the disruption of the PBMs,
- 12:24Speaker 6: your team put things in place.
- 12:26Speaker 5: How long ago was it that you guys started this
- 12:29Speaker 5: seven years ago?
- 12:29Speaker 8: Almost say, I.
- 12:30Speaker 5: Was going to say ten years ago.
- 12:32Speaker 6: But now you've put infrastructure in place to get ready
- 12:35Speaker 6: for the next realm, the next level of the next
- 12:38Speaker 6: generation PBM.
- 12:39Speaker 5: Talk to us about how you're making a difference.
- 12:42Speaker 10: So I think, first of all, first and foremot is
- 12:44Speaker 10: about financial alignment, and that's where the rest of the
- 12:47Speaker 10: industry is missed.
- 12:48Speaker 8: And I think you're seeing the smoke.
- 12:50Speaker 10: Signals from the FTC investigations where you know, we thought
- 12:55Speaker 10: drug costs is a function of both unit price and
- 12:58Speaker 10: drug mix, and we thought that the industry did a
- 13:01Speaker 10: pretty good job of nailing down unit price, which is complicated.
- 13:05Speaker 10: What's a brand, what's a generic? We have got many,
- 13:07Speaker 10: many pages to define that, and most procurement solutions have
- 13:12Speaker 10: three hundred questions about how what is the price of
- 13:15Speaker 10: the drug. The FTC started to uncover when a pharmacy
- 13:19Speaker 10: benefit manager is vertically integrated.
- 13:21Speaker 8: That maybe the price isn't so competitive anymore and.
- 13:24Speaker 10: You have three thousand percent increases on a top So
- 13:26Speaker 10: that was one piece of it, and we're starting to
- 13:29Speaker 10: see that the other piece of it that everybody missed.
- 13:32Speaker 8: It's those thousand decisions that PBMs make.
- 13:35Speaker 10: Is the management part of it that drives drug mins.
- 13:39Speaker 10: What is the formulary, How aggressive or good or clinical
- 13:43Speaker 10: are the clinical programs?
- 13:45Speaker 8: How many too many fills do they have?
- 13:47Speaker 10: And I think we've all been bombarded by fill your
- 13:49Speaker 10: prescription and you end up with fifteen months of therapy
- 13:52Speaker 10: in your medicine.
- 13:52Speaker 8: Cavin all of that ballooned healthcare. Nobody cared when prescription
- 13:57Speaker 8: drugs was five percent of healthcare spin.
- 13:58Speaker 10: But with prescription drugs being thirty person spend, it's really
- 14:01Speaker 10: kind of shehone a light on our industry, which most
- 14:04Speaker 10: people don't even know what a pharmacy benefit manager was
- 14:06Speaker 10: until recently.
- 14:08Speaker 6: All Right, so the pharmacist as part of this ecosystem.
- 14:12Speaker 6: To me, it should be the pharmacist, the physician, the
- 14:16Speaker 6: patient and then those three entities and the whole ecosystem
- 14:22Speaker 6: should be surrounded by technology and the PBM and insurance.
- 14:26Speaker 6: But that doesn't feel like it's that way with the
- 14:29Speaker 6: traditional PBMs. With you, you do come at this from
- 14:32Speaker 6: a clinical perspective, share with us that vision of this
- 14:36Speaker 6: next gen PBM.
- 14:38Speaker 10: Well, I feel in in complete agreement with you. I
- 14:40Speaker 10: feel like the US healthcare system in general has been
- 14:43Speaker 10: more of a sick care system instead of a healthcare system,
- 14:46Speaker 10: And it circles back to that idea of financial misalignment.
- 14:50Speaker 8: The partner that you select, do they.
- 14:53Speaker 10: Make more money and does it benefit them? Not necessarily
- 14:56Speaker 10: the patient that the more you spend or the more
- 14:59Speaker 10: the spends, the more they make. We all know doctor
- 15:02Speaker 10: Google out there, you see a commercial, you ask your
- 15:04Speaker 10: doctor for that.
- 15:06Speaker 8: Medication on TV. It may not be the safest medication
- 15:09Speaker 8: for you. You know, typically the drugs.
- 15:11Speaker 10: That have been used more often or safer, we understand
- 15:15Speaker 10: more about them clinically, and so how does it help
- 15:18Speaker 10: the patient? If the doctor says yes, the PBM says yes,
- 15:21Speaker 10: when they're supposed to be the oversight because you know,
- 15:24Speaker 10: you may have several doctors in your repertoire that that
- 15:27Speaker 10: doctor doesn't know what the other doctor's doing. If the
- 15:29Speaker 10: PBM just says rubber stamp yes, yes, yes, feels more
- 15:33Speaker 10: and more medication, that's not looking out in your best interests,
- 15:37Speaker 10: because if you think about it, a topical cream is
- 15:39Speaker 10: safer for you than an injection. Then less than three
- 15:42Speaker 10: percent of the population has taken. Just the pharmacist in
- 15:45Speaker 10: me knows, and we should all know.
- 15:47Speaker 8: It takes many, many years, ten years for us to
- 15:50Speaker 8: really understand.
- 15:51Speaker 5: The side effects.
- 15:51Speaker 10: So if we can get away with treating your disease
- 15:54Speaker 10: with a topical cream, that's what we want to do.
- 15:56Speaker 8: So let me circle that back to Capital RX. It's
- 16:00Speaker 8: safer because we're more clinically alone.
- 16:02Speaker 10: We're following those guidelines that you know when the drugs
- 16:05Speaker 10: were approved, how they were supposed to be taken.
- 16:08Speaker 8: And I'm going to give an example that everybody.
- 16:10Speaker 10: Would understand stomach and alserve medications, pylosec nexium, all those
- 16:15Speaker 10: medications they were supposed to be taken for six weeks
- 16:18Speaker 10: maybe at a time. We popt them like candy and
- 16:21Speaker 10: what did we learn later after ten or fifteen years
- 16:24Speaker 10: of everybody taking too much of that medication and I
- 16:27Speaker 10: lead to stomach cancer because you've shut down those things.
- 16:29Speaker 10: So any patient, whether it be your parent, yourself, whoever
- 16:33Speaker 10: your child, do you want them to start with the
- 16:35Speaker 10: older generation product that maybe have we understand more about it.
- 16:39Speaker 10: When your pbum isn't aligned, they'll say, yes, take that
- 16:42Speaker 10: latest drug.
- 16:43Speaker 8: Usel on TV. It's not us for patient care.
- 16:48Speaker 6: All right, so let's talk about business development and expansion.
- 16:51Speaker 6: So are you able to partner with community pharmacies that
- 16:56Speaker 6: our business savvy. Some of our independent community pharmacies are
- 17:00Speaker 6: stuck in apothecary style days and they have to quickly
- 17:05Speaker 6: understand the lunch is being eaten by your PBMs. You
- 17:09Speaker 6: better start getting a little bit more aggressive. So does
- 17:11Speaker 6: Capital RX tell us how you're partnering with independent community
- 17:14Speaker 6: pharmacies to go into their community and pitch a school
- 17:18Speaker 6: district or pitch a small employer, Like, how are you
- 17:20Speaker 6: doing that?
- 17:21Speaker 10: So, first of all, we use a completely different pricing basis.
- 17:25Speaker 10: We use NAK National Average Drug Acquisition Costs, which you're
- 17:29Speaker 10: the first PBM to come to industry to use it.
- 17:31Speaker 10: There's a sprinkling of NADAK here and there, which that
- 17:34Speaker 10: is a cost plus model for any pharmacy.
- 17:38Speaker 8: We don't want them to go underwater. We cannot have
- 17:41Speaker 8: healthcare deserts.
- 17:42Speaker 10: You cannot get everything from mail order or anywhere else
- 17:45Speaker 10: that you're going. So we want to give them a
- 17:47Speaker 10: full and fair dispensing fee and not have them try
- 17:51Speaker 10: to figure out maclists which have been abused by the
- 17:54Speaker 10: PBM industry and it's a very volatile moment for a
- 17:58Speaker 10: retailer and a lot of drugs are underwater, and that
- 18:02Speaker 10: just doesn't seem like a fair thing to pay them
- 18:04Speaker 10: for their knowledge base. And let's be honest, pharmacists are
- 18:06Speaker 10: frontline markers. They're there to help us. And often people
- 18:11Speaker 10: are more honest with their pharmacists and they are even
- 18:13Speaker 10: their physician.
- 18:14Speaker 8: They're just more comfortable with them.
- 18:15Speaker 10: So we can't be pushing them out of business. And
- 18:18Speaker 10: you know, oftentimes we get asked to testify at states
- 18:21Speaker 10: like you're the good guy, PBM, you're making money? How
- 18:25Speaker 10: are you working in partnership with pharmacies?
- 18:28Speaker 8: And it's a nat ACT based.
- 18:29Speaker 10: Model that we work a model and give them a
- 18:31Speaker 10: full and fair dispensing fait.
- 18:33Speaker 6: How does specialty pharmacy change the game in the realm
- 18:36Speaker 6: of capital rxes involved.
- 18:39Speaker 10: Well, especially so say two to three percent of drugs
- 18:41Speaker 10: are specialty, they drive fifty percent of total healthcare spend.
- 18:46Speaker 8: So it really is about what drugs do you approve.
- 18:49Speaker 10: For the patient and that's what driving the plan sponsors
- 18:52Speaker 10: total costs. So we're just more clinically rigorous when it
- 18:56Speaker 10: comes to is this the right drug for the right person.
- 18:59Speaker 8: At the right times. It's the severity of your disease.
- 19:03Speaker 10: Truly warrant that this is the drug you should be on,
- 19:06Speaker 10: because I mean, nothing else really matters. And I think,
- 19:10Speaker 10: you know, my career started in you know, a manage
- 19:12Speaker 10: care residency after pharmacy school, and then it went into consulting,
- 19:15Speaker 10: and over those years in consulting and even working in
- 19:18Speaker 10: a technology company, what I learned was it was less
- 19:22Speaker 10: about the discounts and rebates that we negotiated.
- 19:24Speaker 8: We kept negotiating quote unquote what.
- 19:26Speaker 10: I call better contracts, and ultimately my client's cost just
- 19:30Speaker 10: kept going up and up.
- 19:31Speaker 8: And I'm talking fortune five hundred clients, and I.
- 19:34Speaker 10: Really started to understand it's less about discounts and rebates
- 19:37Speaker 10: and it's much more about what drug was approved and
- 19:41Speaker 10: how many units were approved, which who controls that the PBM.
- 19:46Speaker 8: So you don't want a PBM.
- 19:47Speaker 10: That has more than one customer, and that's a plague
- 19:51Speaker 10: that is in our industry.
- 19:52Speaker 11: All other PBMs besides Capital RX, really have pharma as
- 19:57Speaker 11: a customer where they're making money off of rebates and
- 20:00Speaker 11: there's other access fee. Every penny that comes in through
- 20:04Speaker 11: better negotiation of dispensing fees at the retail pharmacies that
- 20:08Speaker 11: I would call full and fair per claim or anything
- 20:10Speaker 11: that comes in.
- 20:11Speaker 8: On rebates gets passed back to our planned sponsors. Whether
- 20:14Speaker 8: you're fifty.
- 20:16Speaker 10: Lives, fifty thousand lives, or five hundred thousand lives, think
- 20:19Speaker 10: about that is a wild concept.
- 20:21Speaker 8: Liberatory costs what Liberatory costs.
- 20:23Speaker 10: And whether my client is fifty lives a health plan
- 20:26Speaker 10: that's five hundred thousand lines.
- 20:27Speaker 8: When they access those contracts through US.
- 20:29Speaker 10: And they don't have to, they could use us for
- 20:31Speaker 10: adjudication and have other contracts, but those that access US,
- 20:35Speaker 10: we think that there should be equity.
- 20:36Speaker 8: And drunk pricing. And from California to Ohio to Alabama.
- 20:41Speaker 10: New York City, Lipatoria costs what lipatire costs, and that's
- 20:44Speaker 10: about equity.
- 20:45Speaker 8: It is the most access healthcare benefit. And if we're
- 20:49Speaker 8: making it unfair because you're a small employer versus a
- 20:51Speaker 8: large employer, you're robbing Peter to pay Paul. Because that's
- 20:54Speaker 8: what happens in the standard PBM deals.
- 20:57Speaker 10: Your deal gets old, I make more money off of you,
- 21:00Speaker 10: and then I pull that out.
- 21:01Speaker 8: That's what the industry does.
- 21:03Speaker 10: We are absolutely aganto that it does not work in
- 21:06Speaker 10: our model. That way, we only make money on an
- 21:08Speaker 10: admin fee, which keeps us.
- 21:10Speaker 8: Aligned to our customers. They are only customers.
- 21:13Speaker 10: And you know, partnership with retailers at the same time
- 21:17Speaker 10: keeping them in business because you know, if you live
- 21:19Speaker 10: in a rural area, you got to be able to
- 21:21Speaker 10: fill an in abotic.
- 21:22Speaker 8: You can't be airdropped to your house.
- 21:24Speaker 6: Right. It's fun to hear you say things from your
- 21:28Speaker 6: career progression because there are pharmacy students listening to these
- 21:33Speaker 6: shows right now, to let them know that your view
- 21:38Speaker 6: of pharmacy and what you can do as a pharmacist
- 21:42Speaker 6: may be completely different than what you thought, and you
- 21:45Speaker 6: are a testimony to that as a business driven pharmacist
- 21:49Speaker 6: who sees things clinically, but then you're backing that up
- 21:53Speaker 6: with all of your contracting and business creation. And I
- 21:57Speaker 6: think that's special. So shout out to pharmacists out there
- 22:00Speaker 6: and in our upcoming future pharmacists out there. There's a
- 22:04Speaker 6: lot you can do with a farm d these days,
- 22:06Speaker 6: doesn't necessarily have to put you behind a counter.
- 22:09Speaker 8: Per SECT does absolutely correct well.
- 22:12Speaker 5: We enjoyed having you on the show.
- 22:14Speaker 6: Always been big fans of AJ and your team at
- 22:17Speaker 6: capital Rx website. Capitrx dot com. You got it all right,
- 22:21Speaker 6: capital rx dot com. Make a change in your PBM.
- 22:25Speaker 6: Reach out to Kristen and team. Thank you for being
- 22:27Speaker 6: part of the show.
- 22:28Speaker 8: Thanks for having.
- 22:34Speaker 6: Doctor eric Abel here at hl THH. Eric you and
- 22:38Speaker 6: I connected through LinkedIn. We're fellow Pittsburgh Steeler fans. We
- 22:43Speaker 6: never get time to spend together, and now we met
- 22:45Speaker 6: each other here in Vegas.
- 22:47Speaker 12: You got to come to Vegas to hang out, man,
- 22:49Speaker 12: no better place.
- 22:50Speaker 5: Right, all right?
- 22:51Speaker 6: Tell our listeners who is eric Abel? What do you
- 22:54Speaker 6: do in the realm of healthcare?
- 22:56Speaker 5: Why are you at hlt SO.
- 22:58Speaker 12: I'm at hlt H. I'm with a company.
- 23:01Speaker 13: I'm actually with a startup named Caption Health that was
- 23:05Speaker 13: acquired by ge Healthcare almost two years ago. I lead
- 23:09Speaker 13: a lot of the clinical innovation work and strategy with
- 23:13Speaker 13: Caption Care, which is into in turnkey service for cardioc
- 23:17Speaker 13: dagnostics with a cook cardiograms, so AI enabled and really
- 23:22Speaker 13: solving for some gaps in early proactive care in cardiology.
- 23:27Speaker 5: So ERIQ.
- 23:27Speaker 6: We're just talking to me before we started recording about
- 23:31Speaker 6: the silliness that happens in healthcare where people are in
- 23:35Speaker 6: the hospital now all of a sudden, they're being transitioned out.
- 23:38Speaker 6: Now they go home, they have medication regimens. Things start
- 23:43Speaker 6: to fall apart. Now they become an adherent, Like, talk
- 23:46Speaker 6: to me about some of the ideas that you have
- 23:48Speaker 6: to fill those gaps in and make the transitions better.
- 23:51Speaker 13: Yeah, I mean, there's I could talk all day about
- 23:54Speaker 13: some of these things. I'm a pharmacist by background, so
- 23:56Speaker 13: really kind of atypical to be in.
- 23:58Speaker 12: An imaging organization in general.
- 24:00Speaker 13: But I've been on both payer provider and now really
- 24:03Speaker 13: life sciences REALM. I think the most important thing is
- 24:07Speaker 13: connecting to the needs of the providers, connecting really more so,
- 24:11Speaker 13: helping them solve the issues for the patients. Some of
- 24:14Speaker 13: that is how can we keep them out of the
- 24:16Speaker 13: hospital so you can't treat what you don't know about.
- 24:20Speaker 13: And you think about the admissions that happened because somebody
- 24:22Speaker 13: doesn't have access to key diagnostics, and you know there's pharmacists,
- 24:27Speaker 13: and you know within what five miles of every you know,
- 24:30Speaker 13: old statistic is within five miles of every resident with
- 24:33Speaker 13: the country, whether that's still true or not with all them,
- 24:37Speaker 13: So what's that looked like today? But I still think
- 24:40Speaker 13: of the transitions of care. I mean there's the business models,
- 24:44Speaker 13: and the need for business models for pharmacists, nurses and
- 24:47Speaker 13: others is what's missing. I think in some of the
- 24:50Speaker 13: healthcare for cognitive they're cognitive contributions. How if you want
- 24:55Speaker 13: things to change, you have to figure out how to
- 24:58Speaker 13: actually work to get there.
- 25:00Speaker 12: So I think of.
- 25:03Speaker 13: Older days of your past lives of you know, in
- 25:06Speaker 13: the academic medical center world, you have pharmacists involved in
- 25:09Speaker 13: perioperative settings to get into drug reviews, making sure we
- 25:12Speaker 13: don't have medication misadventures, hoping that we can control the
- 25:16Speaker 13: controls before they come in. You think of the folks
- 25:19Speaker 13: that are in eds, you know, the pharmacists playing a
- 25:21Speaker 13: role there with the nurses. You think of like the
- 25:24Speaker 13: discharges and like, well I'm holding on to the discharge
- 25:27Speaker 13: because they don't have key access to you know, sonographers
- 25:30Speaker 13: who are in shortage. There's thirteen thousand cardiac dreat scenographers
- 25:33Speaker 13: in the US. Not enough, there's seventy four thousand sonographers
- 25:37Speaker 13: in total. But if I can actually help democratize, That's
- 25:40Speaker 13: really where I'm at today, is like, if if I
- 25:43Speaker 13: can help primary care be use a specialty solution with
- 25:47Speaker 13: the with really the change.
- 25:49Speaker 12: Of management tools needed.
- 25:50Speaker 13: Yep, I can even if they need a full turnkey
- 25:53Speaker 13: service or partial I can help bring in folks in
- 25:57Speaker 13: the clinic or into the patient's home. Do some cardiac
- 25:59Speaker 13: dignom sticks to help understand with an echo cardiogram do
- 26:02Speaker 13: they have structural heart disease? Can I get them on
- 26:05Speaker 13: the foundational medications needed and hopefully avoid the hospitalization? Wait
- 26:09Speaker 13: for you know that if there's I think one of
- 26:11Speaker 13: the statistics built you know, published a couple of years
- 26:14Speaker 13: ago was.
- 26:15Speaker 12: With incident heart failure.
- 26:17Speaker 13: Uh, there's thirty eight percent of new diagnosed incident heart
- 26:21Speaker 13: failure that is not diagnosed.
- 26:23Speaker 12: Until in the walls of the hospital.
- 26:24Speaker 13: Forty eight percent of those we actually had symptoms documented
- 26:29Speaker 13: consistent with heart failure in the six months prior to
- 26:32Speaker 13: their mission. So it begs the question of ambulatory sense
- 26:35Speaker 13: of conditions and so is that you know, is that echo?
- 26:39Speaker 10: Is that lab?
- 26:40Speaker 13: Is that just education and awareness of the general community
- 26:43Speaker 13: of providers.
- 26:44Speaker 12: Is that a reluctance in patient engagement?
- 26:47Speaker 13: I think it just begs a lot of questions of
- 26:49Speaker 13: how can we approach things differently. But if you want
- 26:52Speaker 13: to be able to people to practice in different areas
- 26:55Speaker 13: and start going there. I think a lot of it
- 26:57Speaker 13: begins with what is the you know I think of
- 27:00Speaker 13: I go back to the pharmacy business model, and luckily
- 27:03Speaker 13: in the outpatial world, we're starting to see changes, right,
- 27:06Speaker 13: you know, pharmacists being paid for different types of services.
- 27:08Speaker 12: The MTM was a was a beginning. It cannot be
- 27:11Speaker 12: the end.
- 27:12Speaker 13: Dispensing services really not the place where you know, the
- 27:16Speaker 13: independent pharmacies are really contributing.
- 27:18Speaker 12: Value and that relationship in the communities.
- 27:20Speaker 13: And so how can we think of other ways, whether
- 27:23Speaker 13: that's transitions of care, deeper scribing, whether that's you know,
- 27:27Speaker 13: because deeper scribing is like that's the med that that's
- 27:29Speaker 13: there that shouldn't be right, And so for a lot
- 27:33Speaker 13: of different reasons. And there's whether it's there pharmaco therapeutic monitoring,
- 27:38Speaker 13: you know, drug levels and things like that. There's a
- 27:41Speaker 13: lot of different areas where I think if we put
- 27:44Speaker 13: the help support new ways and new reimbursement models for
- 27:48Speaker 13: those types of clinicians. You know, nurses do a lot
- 27:51Speaker 13: in the community too, and we're reaching a critical shortage.
- 27:53Speaker 12: We've got to be able to build a business.
- 27:55Speaker 13: Model to build the demand to have people come in
- 27:58Speaker 13: and practice in those areas, but what else we're faced
- 28:00Speaker 13: with other problems?
- 28:02Speaker 6: Eric, The reason why we have so much breaks is
- 28:05Speaker 6: there's no one entity that's controlling that flowing process. So
- 28:10Speaker 6: when I think of community pharmacies that are empowered by
- 28:13Speaker 6: I Care Plus, for example, we're here at Independent Pharmacy
- 28:17Speaker 6: Cooperatives booth, so they're teaching their member and their pharmacist
- 28:22Speaker 6: to dial into the treatment plan and drive it regardless
- 28:27Speaker 6: of where it comes from. So if it comes from
- 28:29Speaker 6: the hospital physician, or it comes from the general practice,
- 28:33Speaker 6: or it comes from some special specialist IPC saying we
- 28:38Speaker 6: don't care. We want to pick up the football and
- 28:40Speaker 6: we want to run with it and then report back
- 28:42Speaker 6: to the EHR. And there there is why I'm at
- 28:46Speaker 6: This is why I'm at Henths. I want to connect
- 28:48Speaker 6: people like you with this kind of organization and saying, okay, pharmacists,
- 28:53Speaker 6: we're going to have to control this because there is
- 28:55Speaker 6: no one entity it's driving.
- 28:58Speaker 12: Well, think of this is.
- 28:59Speaker 13: Where I think of you and like and I think
- 29:01Speaker 13: of the eco cardiogram being one of those modalities because
- 29:05Speaker 13: it's I'm a cardiac trean especially PHARMACISTM But think of
- 29:09Speaker 13: the time in the future, if I could have a
- 29:13Speaker 13: point of care handheld echo cardigram pro that a a phlebotomist,
- 29:19Speaker 13: a nurse assistant, a medical assistant, a pharmacy technician could
- 29:23Speaker 13: be in that local pharmacy they are the practice of
- 29:27Speaker 13: medicine doesn't occur where you're acquiring images, so I have
- 29:32Speaker 13: an AI guide instead tell them turn by turn of
- 29:34Speaker 13: how to capture the images, and then those are routed
- 29:37Speaker 13: to a cloud based packs imaging system where a network
- 29:42Speaker 13: of cardiologists are available there to actually to actually interpret
- 29:46Speaker 13: those and make them available the card Then you have
- 29:48Speaker 13: the pharmacists there, which this is utopia for me, is
- 29:51Speaker 13: like how can I act on this? They have they
- 29:53Speaker 13: have validated stage B heart failure, so structural heart disease,
- 29:57Speaker 13: no symptoms yet can I Are they on the right
- 30:00Speaker 13: anti hypertensive regimen to control their left finger GUI purchasing?
- 30:03Speaker 12: Are they on those other things? And so that beg's
- 30:05Speaker 12: other questions.
- 30:06Speaker 13: Collaborative practice agreements between the pharmacists or provider status of
- 30:11Speaker 13: what they can do, But it's really doing the right thing.
- 30:14Speaker 13: Keeping at the middle, what are we doing for the
- 30:16Speaker 13: patients and helping drive ACCEP affordable, accessible, equitable care across
- 30:22Speaker 13: the US. And I think that partly is the providers
- 30:25Speaker 13: and the organizations. It's the technology, and it's also the
- 30:28Speaker 13: regulatory bodies at the given state boards of you know, nursing, pharmacy,
- 30:34Speaker 13: medicine to align on. Let's actually, can we just understand
- 30:38Speaker 13: what the demands are. We get growing obesity, growing CKD,
- 30:41Speaker 13: growing hypertension. We're begging for problems.
- 30:45Speaker 12: It is.
- 30:46Speaker 13: It's like chumming, you know, chumming for the great, great
- 30:49Speaker 13: white shark in the ocean.
- 30:51Speaker 12: We we've loaded it. We're just waiting for something.
- 30:53Speaker 6: Really bad to appen. All right, this is special finally
- 30:56Speaker 6: getting on the show. Thanks participating on the HLTAH twenty
- 31:00Speaker 6: twenty four post show. Promise that you're gonna come down
- 31:03Speaker 6: to the HQ studios.
- 31:05Speaker 12: I promise as we're going to be there.
- 31:06Speaker 5: Man, Thank you sir, great to see you.
- 31:14Speaker 14: I heard you had a long shift.
- 31:16Speaker 7: This is the.
- 31:18Speaker 6: Doctor Jmax Slaughter m D Show here live at HLTH
- 31:24Speaker 6: twenty twenty four.
- 31:26Speaker 14: Just kick off those feet, just listen for a little while.
- 31:29Speaker 5: And uh and just drift away.
- 31:33Speaker 6: Are there any emergency room pharmacist listening right now? Because
- 31:38Speaker 6: you have to follow doctor Jmax Slaughter, MD, and you
- 31:42Speaker 6: like Instagram.
- 31:43Speaker 14: Yeah, Instagram is I would say my primary right now,
- 31:46Speaker 14: you can find me pretty hopefully easily. There aren't too
- 31:49Speaker 14: many doctor dot Jmax out there. But you know what,
- 31:52Speaker 14: my my last name that I go by in the
- 31:54Speaker 14: eers is.
- 31:56Speaker 5: Doctor Slaughter, doctor Slaughter, which is a it's a truth.
- 32:00Speaker 15: I'm with the knife.
- 32:01Speaker 14: Yeah, my patient's always that. Come in the room, I'm
- 32:03Speaker 14: doctor Slaughter. Nice to meet you. And they kind of
- 32:05Speaker 14: don't really hear my name, and then they look at
- 32:08Speaker 14: my white coat and they're like, oh my, you're actually
- 32:10Speaker 14: doctor slaughterly.
- 32:11Speaker 5: Doctor Slaughter, and then I make sure they know it's
- 32:15Speaker 5: You're like, it's just a pun. Don't don't worry, don't
- 32:17Speaker 5: just put this mask on the ship. I think'st I
- 32:20Speaker 5: think it's gonna be funny. Well, I followed you for
- 32:23Speaker 5: a while. I've been a fan. It's so cool to
- 32:25Speaker 5: meet up with you at h hlt H. Why are
- 32:28Speaker 5: you here? What is it about digital health and the
- 32:31Speaker 5: er and the fusion of what you do? Talk to
- 32:33Speaker 5: us about. What's what that's all about?
- 32:35Speaker 14: Man, I'm just so excited about where healthcare is going.
- 32:38Speaker 14: Obviously there's a lot of hype now with AI and
- 32:42Speaker 14: the ability for AI to improve the lives of healthcare
- 32:45Speaker 14: workers all around the world. But at the same time,
- 32:49Speaker 14: AI is kind of terrifying, just like just like kind
- 32:51Speaker 14: of I think everybody has in the back of your minds,
- 32:54Speaker 14: how is it going to improve our lives? Or how
- 32:56Speaker 14: is it how is it going to dig our chance away?
- 32:58Speaker 5: You know, parts of the.
- 33:00Speaker 14: Yeah, there are parts of them, and there's some parts
- 33:02Speaker 14: of them that we are just very very willing, I think,
- 33:04Speaker 14: to give away. But others that I mean give us
- 33:08Speaker 14: our sense of purpose in life and and and obviously
- 33:12Speaker 14: there's the financials behind that too. So it's a it's
- 33:14Speaker 14: a heavy it's a heavy topic, and I want to
- 33:16Speaker 14: understand more about what's coming.
- 33:18Speaker 5: Are you speaking here, are you on a panel or
- 33:20Speaker 5: anything like that.
- 33:21Speaker 14: I'm here with a group of medical creators called Medfluencers,
- 33:28Speaker 14: and basically it's it's people mostly physicians, but we also
- 33:34Speaker 14: are working with pharmacists and nurses in the social media
- 33:37Speaker 14: space to help them navigate the really difficult territories when
- 33:42Speaker 14: you know, because people are coming to us and they're
- 33:44Speaker 14: offering us X number of dollars to promote their their brand,
- 33:47Speaker 14: whatever that is, and some brands don't have any regulation
- 33:51Speaker 14: behind it. Some of them. If you're taking on that deal,
- 33:54Speaker 14: you're actually taking on an enormous amount of liability and
- 33:58Speaker 14: your credentials may be at risk, and you don't realize that.
- 34:00Speaker 14: And so we're kind of the first ones in the
- 34:02Speaker 14: space to be like, hey, if you're going to do
- 34:06Speaker 14: these things, and you know, it's only inevitable that more
- 34:11Speaker 14: and more marketing dollars go to social media because that's
- 34:13Speaker 14: where people are. People aren't watching TV, people aren't listening
- 34:16Speaker 14: to the radio, they're listening to podcasts, and they're on
- 34:18Speaker 14: social media. And so it is an inevitable move for
- 34:22Speaker 14: all these big worldwide companies to move to market on
- 34:25Speaker 14: social media. And with certain things you need, you need
- 34:30Speaker 14: to have your credentials protected. And so that's one of
- 34:34Speaker 14: the things that Medfluencers kind of focuses.
- 34:36Speaker 5: On med influencers.
- 34:38Speaker 6: Medfluencers exactly, how do the pharmacists listening right now, how
- 34:43Speaker 6: do they connect with you?
- 34:45Speaker 14: You can follow us on on Instagram or TikTok at
- 34:48Speaker 14: we are Medfluencers, and or just go to I think
- 34:52Speaker 14: it's just medfluencers dot com.
- 34:54Speaker 15: I shouldn't know that.
- 34:55Speaker 14: Yeah, it's just medfluencers dot com and you can just
- 34:58Speaker 14: send us a little message and we can get you
- 35:01Speaker 14: into the system. Because ultimately what we're doing is we're
- 35:03Speaker 14: creating a very large database. We already have over four
- 35:06Speaker 14: hundred what we call d o ls you know, KOLs.
- 35:10Speaker 14: This is something that's been around for a long time.
- 35:12Speaker 14: But yeah, now there are digital opinion leaders and you're
- 35:15Speaker 14: one of them.
- 35:15Speaker 5: Yes, I try to be. I'm gonna have to join.
- 35:18Speaker 6: I'll be the non clinical you go there, you go, well,
- 35:22Speaker 6: I'm excited to have you part of the show. This
- 35:24Speaker 6: goes out to thousands of listeners every month. They're all
- 35:27Speaker 6: pretty much pharmacists. I want to say that we're going
- 35:30Speaker 6: to have doctor Mac back on to fuse up a
- 35:33Speaker 6: discussion with a couple er pharmacists to just talk shop
- 35:37Speaker 6: with you, and I would.
- 35:37Speaker 5: Love to have you.
- 35:38Speaker 14: There'll be drink works and I heard there was tworking involved,
- 35:41Speaker 14: and that's how you got my attention. You're like, hey,
- 35:43Speaker 14: do you like twerking sir? And and you're like, come
- 35:46Speaker 14: on my podcast, Okay, come in as long as there're trko.
- 35:49Speaker 6: That's right, all right, Stay tuned for more Doctor Mac
- 35:52Speaker 6: coming up on this week in pharmacy. Hey, Matthew, what
- 36:03Speaker 6: a great opportunity to meet someone who is focused on
- 36:08Speaker 6: digital health. But you slowed me down because I'm too
- 36:11Speaker 6: excited over here, and you're like, but what about the patient?
- 36:14Speaker 6: You know, what about the sixty five expansion of our
- 36:19Speaker 6: seniors in the United States, for example, It's going to
- 36:22Speaker 6: be a major issue over the next twenty years when
- 36:24Speaker 6: they multiply, multiply and multiply that are going to need
- 36:27Speaker 6: special services. And now we're relying on technology that adoption
- 36:33Speaker 6: is sometimes a struggle. So talk to me about your
- 36:37Speaker 6: experience here at hl THH and I want to talk
- 36:40Speaker 6: about idea fantastic.
- 36:42Speaker 15: Well, thanks for having me, Todden. Very good to be here.
- 36:45Speaker 15: It's been an awesome few days and this is a
- 36:48Speaker 15: good way for me to wrap up some of the
- 36:51Speaker 15: great conversations that I've been having. So as I believe
- 36:54Speaker 15: you know, and some of your listeners might be a
- 36:56Speaker 15: whare IUDEO is a global innovation design and innovation firm.
- 37:00Speaker 15: We specialize in putting humans at the center of the
- 37:03Speaker 15: experiences and strategies and organizations that we design in service
- 37:08Speaker 15: of healthier human centered futures. And yeah, to your point
- 37:14Speaker 15: around the expanding patients that are requiring elder care. It's
- 37:23Speaker 15: a growing and well foreseen area of the population that
- 37:32Speaker 15: needs to be designed for. And it's not just that
- 37:35Speaker 15: the care recipients, it's the caregivers. It's the communities that
- 37:38Speaker 15: they sit in, all of which needs consideration when we're
- 37:40Speaker 15: thinking about designing for those digital and non digital experiences.
- 37:46Speaker 6: You and I have an advantage just in the generation
- 37:49Speaker 6: that we live within. I'm Gen X and I remember
- 37:56Speaker 6: my corded phone against the.
- 37:58Speaker 5: Law and tech.
- 38:00Speaker 6: The high tech in our house was a twenty foot
- 38:03Speaker 6: cord that I could get away from my mother listening
- 38:05Speaker 6: to my conversations. And then that evolved. We finally got
- 38:09Speaker 6: our remote phone, mobile phone. Then it kept evolving. So
- 38:14Speaker 6: the reason why I mentioned that is who you're saying
- 38:17Speaker 6: might be struggling with technology.
- 38:19Speaker 5: I know those.
- 38:20Speaker 6: People like my dad my mom are way ahead now
- 38:25Speaker 6: because they've been saturating in it for as long as
- 38:28Speaker 6: all of us. But I remember when the first non
- 38:33Speaker 6: key phone came out. It was just a flat screen.
- 38:36Speaker 6: It was just a glass screen, and I have to admit,
- 38:40Speaker 6: I was like, this is stupid, Like how am I
- 38:42Speaker 6: gonna what if?
- 38:43Speaker 5: You know?
- 38:44Speaker 6: How am I going to interact and now we don't
- 38:46Speaker 6: even think of that way. Now, the next generation, my children,
- 38:52Speaker 6: my grandchildren can't believe I'm saying that, but got three
- 38:56Speaker 6: and they're never.
- 38:57Speaker 5: Going to experience. But you and I.
- 38:59Speaker 6: Experienced in the evolution of using tech like that, usable tech, right,
- 39:04Speaker 6: IDEO is bringing something special to this game because you're
- 39:08Speaker 6: slowing it down a little bit. People like me design,
- 39:12Speaker 6: you know, software designers. Sometimes they're designing for the endgame
- 39:18Speaker 6: without thinking about the journey from the patient's perspective.
- 39:21Speaker 15: Yeah, right, yeah, right on. And isn't it interesting that
- 39:25Speaker 15: the next generation your grandchildren that are coming through are
- 39:27Speaker 15: going to have experiences that we will never have. You know,
- 39:30Speaker 15: that's a cycnical kind of wonderful nature of development. But yeah,
- 39:36Speaker 15: from a from a needs standpoint, I guess the work
- 39:41Speaker 15: that we're doing in digital health and across emerging technologies,
- 39:44Speaker 15: there's always been technologies that have come to the fore
- 39:47Speaker 15: and need to be designed for leads with desirability. You know,
- 39:51Speaker 15: there's a lot of people running around with solutions with hammers,
- 39:55Speaker 15: and when you're running around with a hammer, everything looks
- 39:57Speaker 15: like a nail. Yes, but if you can take it
- 40:00Speaker 15: and design well, understand the needs of the patients, the caregivers,
- 40:07Speaker 15: the providers that are the critical interface for for the
- 40:14Speaker 15: administrative administrating this care, the doctors, the nurses, the administrative staff.
- 40:20Speaker 15: We're actually well understanding the needs of each of these
- 40:24Speaker 15: humans in there, we can design far more engaging, sustainable,
- 40:29Speaker 15: compelling experiences that will stand the test of time and
- 40:35Speaker 15: actually will achieve the things that we're out there trying
- 40:38Speaker 15: to achieve that they're going to have the impact with
- 40:40Speaker 15: the elderly, the elder community in the same way as
- 40:43Speaker 15: the as the younger individuals that are coming through that
- 40:47Speaker 15: have very different, different, very different needs. IDEO we've recently
- 40:52Speaker 15: designed for both ends of those scales, working with together
- 40:56Speaker 15: Senior Health to to design their next generation dementia platform
- 41:02Speaker 15: and at the other end of the scale, working with
- 41:04Speaker 15: KUTH to launch a brand new mental health experience for
- 41:09Speaker 15: young people in California. So we're very used to designing
- 41:12Speaker 15: for both ends of the scale and leading with desirability.
- 41:15Speaker 15: What's the thing that these people need in order to
- 41:18Speaker 15: address the problems that they're experiencing today and tomorrow.
- 41:21Speaker 6: Matthew, give us an example of an IDEO project that
- 41:24Speaker 6: you're proud of that touches the world of medication management somewhere.
- 41:31Speaker 15: Happy to We've recently worked on a vaccine, a vaccine
- 41:37Speaker 15: that launched last year, and the work that we were
- 41:42Speaker 15: doing was bridging the knowledge that caregivers, in this case,
- 41:53Speaker 15: the knowledge gap that caregivers had around the importance of
- 41:56Speaker 15: this vaccine and why it should be administered to their
- 42:00Speaker 15: vulnerable weeks old baby. And so the work that we
- 42:04Speaker 15: were doing was understanding the modes that those caregivers, those
- 42:09Speaker 15: parents and caregivers would be in, the modes that the
- 42:12Speaker 15: physicians and the doctors are in, and designing conversation tools
- 42:17Speaker 15: to bridge that gap to help with the understanding that
- 42:20Speaker 15: both caregivers need and that doctors need to need to provide.
- 42:25Speaker 15: We did that globally and it's amazing to be designing
- 42:28Speaker 15: for all of the different health systems in the States,
- 42:31Speaker 15: in France, out in China to understand what are the
- 42:35Speaker 15: tools that they need to have the human conversation about
- 42:38Speaker 15: the importance of these vaccines.
- 42:46Speaker 5: I've been at hl THH.
- 42:47Speaker 6: This is only the second time that the Pharmacy Podcast
- 42:50Speaker 6: Network has been here, and every time I open the app,
- 42:53Speaker 6: I see norm and I'm like, what is this? So
- 42:58Speaker 6: you're in my booth now in NOOM is here and
- 43:01Speaker 6: I want to introduce Yalda Allcott farm D. Doctor Allcott,
- 43:05Speaker 6: you're the right D. It's the farm D and that's
- 43:09Speaker 6: the right person to be here because of my favorite people.
- 43:11Speaker 6: You had me at farm D if I were Jerry
- 43:12Speaker 6: McGuire and Stead, if you had me at Hello, you
- 43:15Speaker 6: had me at farm D.
- 43:17Speaker 7: Well, thank you, thank you for having me on your podcast.
- 43:19Speaker 7: I'm really excited to be here.
- 43:21Speaker 5: All right.
- 43:21Speaker 6: So how does a farm D go to a tech
- 43:23Speaker 6: company and revolutionize what's happening in healthcare and leveraging digital
- 43:28Speaker 6: health and talk to us about NOOM and the fusion
- 43:31Speaker 6: of a farm D.
- 43:32Speaker 4: Absolutely great question.
- 43:33Speaker 7: So when I went to pharmacy school, I went there
- 43:37Speaker 7: to help people feel better. I joined the traditional path
- 43:41Speaker 7: of being a community pharmacy pharmacist, working in retail pharmacies
- 43:45Speaker 7: for a number of years, and what I love most
- 43:47Speaker 7: of that was being able to help people. However, through that,
- 43:51Speaker 7: I've also been passionate about growth and trying different things.
- 43:55Speaker 7: So I've ventured out in my career and what's always
- 44:00Speaker 7: stood true is that that desire to help people.
- 44:04Speaker 8: So when this opportunity came to join New.
- 44:07Speaker 7: I had heard success stories from many people that I
- 44:10Speaker 7: know personally as well as throughout my career that have
- 44:14Speaker 7: had really great success stories at New and they're known
- 44:17Speaker 7: for being innovative, They're known for being an award winning
- 44:22Speaker 7: program that helps people live better lives. And so when
- 44:24Speaker 7: I had the chance to get back to doing that
- 44:27Speaker 7: as a pharmacist, that was exactly where I wanted to be,
- 44:30Speaker 7: and so I joined recently and the Spartsman an amazing path.
- 44:33Speaker 5: Congratulations, thank you.
- 44:35Speaker 6: All right, So there's a bunch of pharmacists listening to
- 44:37Speaker 6: you right now. So now turn on the pharmacist language
- 44:41Speaker 6: and describe to another pharmacist listening what.
- 44:44Speaker 7: Is New sure, So New is a is a company
- 44:49Speaker 7: that is in digital health. We help people feel better
- 44:53Speaker 7: and live better lives through behavioral change program. So we
- 44:56Speaker 7: have paired this behavioral change program that's award winning and
- 44:59Speaker 7: proving to help. Traditionally, we start out in the weight
- 45:02Speaker 7: loss space and we are transforming that, but pairing that
- 45:08Speaker 7: with medications helps people have better outcomes. And our focus
- 45:12Speaker 7: is helping people utilize those medications but also adapt behavioral
- 45:18Speaker 7: changes that helps them with long term sustainability of those results.
- 45:22Speaker 7: So when you pair a behavior change program that kind
- 45:27Speaker 7: of rewires how you're thinking about your health and wellness
- 45:30Speaker 7: with the medications to help you kickstart on that wellness journey.
- 45:34Speaker 7: We're putting those two things together and helping people live
- 45:37Speaker 7: better longer.
- 45:38Speaker 5: It's cool.
- 45:39Speaker 6: HLTCH is a special conference. This is my second time.
- 45:43Speaker 6: It's a lightning ship of activity and things happening and
- 45:47Speaker 6: the lighting and it's just wondering.
- 45:49Speaker 5: I just think it's so cool.
- 45:50Speaker 6: So you made decisions to be here, invest in here,
- 45:54Speaker 6: but you also made some special announcements. Can you give
- 45:57Speaker 6: our listeners a little insight into that?
- 45:59Speaker 11: Yeah?
- 45:59Speaker 7: Absolutely, So we made a really big announcement yesterday. We
- 46:02Speaker 7: have entered a partnership that allows us to help clients
- 46:09Speaker 7: to determine if they determine different paths. So what we
- 46:12Speaker 7: know is that eighty one percent of the employers acknowledge
- 46:17Speaker 7: that their employees want GLP one coverage, but the cost
- 46:20Speaker 7: of these medications are so high, so only forty one
- 46:23Speaker 7: percent are covering it today. So what we announced yesterday
- 46:26Speaker 7: was that we have two solutions, one for the group
- 46:29Speaker 7: of employers that wants to cover that medication, but making
- 46:32Speaker 7: it more affordable for those employers to do so and
- 46:35Speaker 7: then pairing it with our behavior change program so that
- 46:37Speaker 7: we see that long term sustainability with a minimum for XROI,
- 46:41Speaker 7: which is pretty incredible. And then there's the other group
- 46:44Speaker 7: of employers that want to be able to help their
- 46:46Speaker 7: members feel better and have weight loss options without directly.
- 46:51Speaker 8: Covering the cost of GLP ones. So we have solutions
- 46:53Speaker 8: for both.
- 46:54Speaker 5: That's incredible.
- 46:55Speaker 6: So why are those two solutions important to the market.
- 47:01Speaker 5: What's the difference?
- 47:02Speaker 7: Yeah, so they're really important because right now this space
- 47:06Speaker 7: is requiring us to think differently. Every employer has had
- 47:11Speaker 7: rise in healthcare costs as well as interest in GLP
- 47:14Speaker 7: one coverage for their employees, and so it's really important
- 47:18Speaker 7: that we address that gap. Right now, these medications aren't
- 47:21Speaker 7: as accessible as they should be and they're not as
- 47:23Speaker 7: apportable as they should be. Additionally, if people go on
- 47:27Speaker 7: these medications without some behavior change program and lifestyles, they're
- 47:31Speaker 7: at risk of gaining that weight back too, So we
- 47:34Speaker 7: want to ensure that when they're taking these medications it
- 47:37Speaker 7: helps them in the long term.
- 47:39Speaker 6: So I can't help but to think of a special
- 47:43Speaker 6: subject that we paying once every two or three months,
- 47:47Speaker 6: which is digital therapeutics and how a piece of software
- 47:50Speaker 6: will become the prescription and the interaction with the patient,
- 47:57Speaker 6: answering questions, filling out puzzles, dynamic things happen on your screen.
- 48:02Speaker 6: That mental health, addiction, things that are being focused on
- 48:07Speaker 6: are going to be impacted by this digital system that
- 48:11Speaker 6: is a.
- 48:12Speaker 5: Prescription, which I think is really cool. You actually sound
- 48:16Speaker 5: like you're at the knife's edge of being a digital therapeutic. Yeah.
- 48:20Speaker 7: Absolutely, because we're helping patients through cognitive behavior change and
- 48:25Speaker 7: and whatnot.
- 48:26Speaker 4: So we have various.
- 48:27Speaker 7: Programs that help them, help our members adopt their lifestyle,
- 48:31Speaker 7: this new lifestyle. We have rewards, incentives, things of that nature.
- 48:35Speaker 7: We call it new coin that really helps make these
- 48:38Speaker 7: things happen and helps people learn how.
- 48:41Speaker 8: To live better.
- 48:42Speaker 4: And so I agree with you. I think that we
- 48:45Speaker 4: are on that verge and that's where we're headed.
- 48:47Speaker 6: So I'm bias, but I think it's the pharmacist that
- 48:51Speaker 6: is best positioned to use tech like this to marry
- 48:55Speaker 6: it with this pharmacological side of things. Who do you,
- 49:01Speaker 6: I mean, that's kind of a stupid question to set
- 49:03Speaker 6: you up like that, But you've worked with a lot
- 49:06Speaker 6: of HCPs, So where do you see the difference between
- 49:11Speaker 6: our physicians that are really stressed out with how many
- 49:15Speaker 6: patients they have to see per day and then they
- 49:17Speaker 6: kick off the treatment program to the pharmacist. Is new
- 49:21Speaker 6: working between the physician and the pharmacist and kind of
- 49:25Speaker 6: like giving the ball to the.
- 49:28Speaker 5: Pharmacist to run with it.
- 49:30Speaker 4: Yeah, a little bit of both. So you're absolutely right.
- 49:32Speaker 7: So right now, physicians in the United States are extremely
- 49:35Speaker 7: overworked and they can't meet everyone that needs their attention
- 49:39Speaker 7: right So at numere helping solve that too by being
- 49:42Speaker 7: able to see patients right away and being able to
- 49:44Speaker 7: get them the medication and the programs that they need
- 49:48Speaker 7: right off the bat instead of that weeding period. Right now,
- 49:51Speaker 7: if you were to call a you in person physician
- 49:54Speaker 7: and make an appointment, you'd have to wait weeks or
- 49:56Speaker 7: months to get the care that you need. But we're
- 49:59Speaker 7: solving that as well, which is really it's really impactful
- 50:02Speaker 7: and it's really.
- 50:02Speaker 8: Inspiring to be a part of that.
- 50:04Speaker 6: Why don't you come to health and what do you
- 50:05Speaker 6: think of this conference in the center of Innovation and Healthcare?
- 50:09Speaker 7: Yeah, so this is my first time at Health. This
- 50:12Speaker 7: is an amazing conference. There are just so many different
- 50:14Speaker 7: opportunities and partnerships and you know, different companies that are here,
- 50:19Speaker 7: all working towards the same mission and helping people live better.
- 50:23Speaker 7: So it's really exciting to be here and see all
- 50:25Speaker 7: that there is that we can do together.
- 50:27Speaker 6: We hope that you'll come back to the Pharmacy Podcast
- 50:30Speaker 6: Network and let's dig into some other things and talk
- 50:33Speaker 6: farm day.
- 50:34Speaker 7: That sounds great, Okay, Yeah, thanks for having me.
- 50:36Speaker 5: Thank youthful